Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The MSL Execution Factor (Book Review)
Summary
In this episode, Jihad “JR” Rizkallah joins Tom Caravela to delve into the core elements of success for Medical Science Liaisons through the lens of "The Execution Factor." JR emphasizes the significance of vision, passion, and resilience in MSL roles and highlights action as the central hub for effectiveness. The conversation explores overcoming challenges, building robust relationships, and utilizing LinkedIn for meaningful connections. JR also discusses the importance of encouragement, recognition, and the ethos of paying it forward within the MSL community. The episode provides valuable insights for MSLs aiming to enhance their impact and effectiveness in the field.
My guest today is Jihad “JR” Rizkallah, Director, MSLs at Sunovion. JR discusses MSL Execution Factors based on the book by Kim Perell.
JR Shares…
👉 Why he felt compelled to do this specific book review and discussion for the MSL community
👉 What the key factors of Execution are
👉 Why vision and action are so key in your success
👉 Why and how to use relationships to excel in your career as an MSL
👉 How to be resilient and overcome challenges
Medical Science Liaisons, Execution Factor, MSL success, building relationships, resilience in MSL roles
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary